Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Information provision for people with multiple sclerosis.
Multiple sclerosis: KIR4.1 as an autoantigen in MS-new questions raised.
Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function.
Navigating the "liberation procedure": a qualitative study of motivating and hesitating factors among people with multiple sclerosis.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
Reduced Dual-Task Performance in MS Patients Is Further Decreased by Muscle Fatigue.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology.
Sleep loss as risk factor for neurologic disorders: A review.
[Vitamin D and multiple sclerosis].
Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.
Multiple sclerosis: Monotherapy rules.
Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.
Brain atrophy at onset and physical disability in multiple sclerosis.
Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis.
Targeting erythropoietin for chronic neurodegenerative diseases.
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.
Adult-onset vanishing white matter disease as differential diagnosis of primary progressive multiple sclerosis: A case report.

Pages